c-Jun氨基末端激酶

c-Jun氨基末端激酶(c-Jun N-terminal kinase,JNK)是进化保守的丝裂原活化蛋白激酶(mitogen activated-protein kinase,MAPK)超家族的主要成员之一,广泛存在于许多哺乳动物中,参与调节细胞增殖、分化、存活以及凋亡等多种细胞功能。本文主要就JNK的结构特点、生物学功能和作用机制及其在医学研究中的应用进行综述。     

c-Jun/激活蛋白-1活性调节研究进展

转录因子激活蛋白-1(AP-1)对细胞增殖、细胞存活与细胞凋亡等重要生理过程具有调控作用,其核心组成成分是c-Jun.c-Jun活性从转录调控、翻译后调控（主要是磷酸化调节）和相互作用蛋白质调节等三个水平受到正负向调控.其分子内8个位点可被JNK1、GSK3、CKII、Abl等激酶磷酸化.通过N端的转录激活结构域和C端的碱性亮氨酸拉链区,c-Jun可与bZIP类转录因子、辅助激活因子和其他一些蛋白质直接相互作用而被调控.另外一些分子可通过CBP、JAB1等重要辅助激活因子的介导间接调控AP-1的活性,共同构成AP-1活性调节的复杂网络.     

Inhibitors of c-Jun N-terminal kinases: JuNK no more?

The c-Jun N-terminal kinases (JNKs) have been the subject of intense interest since their discovery in the early 1990s. Major research programs have been directed to the screening and/or design of JNK-selective inhibitors and testing their potential as drugs. We begin this review by considering the first commercially-available JNK ATP-competitive inhibitor, SP600125. We focus on recent studies that have evaluated the actions of SP600125 in lung, brain, kidney and liver following exposure to a range of stress insults including ischemia/reperfusion. In many but not all cases, SP600125 administration has proved beneficial. JNK activation can also follow infection, and we next consider recent examples that demonstrate the benefits of SP600125 administration in viral infection. Additional ATP-competitive JNK inhibitors have now been described following high throughput screening of small molecule libraries, but information on their use in biological systems remains limited and thus these inhibitors will require further evaluation. Peptide substrate-competitive ATP-non-competitive inhibitors of JNK have also now been described, and we discuss the recent advances in the use of JNK inhibitory peptides in the treatment of neuronal death, diabetes and viral infection. We conclude by raising a number of questions that should be considered in the quest for JNK-specific inhibitors.     

脑缺血Akt 和MAPK 磷酸酶负性调节c-Jun N 端激酶信号通路

目的:探讨脑缺血再灌后Akt和MAPK磷酸酶与JNK活性下调的关系。方法:采用成年清洁级雄性SD大鼠,建立四动脉阻断前脑缺血再灌注模型。缺血10min后再灌注不同时间(15min,1h,4h,24h)。侧脑室分别给予PI3K抑制剂LY294002(LY)和MAPK磷酸酶抑制剂放线菌酮(CHO)。免疫印迹观察p-Akt和p-JNK蛋白水平变化。结果:脑缺血再灌注4h,JNK的活性能被Akt抑制剂LY294002增强,表明激活的Akt能够下调JNK信号通路。而MAPK磷酸酶抑制剂放线菌酮能上调缺血后JNK活性,提示MAPK磷酸酶通过去磷酸化参与了JNK的活性抑制。结论:前脑缺血再灌后,激活Akt和MAPK磷酸酶参与了JNK信号通路负性调节,是抑制JNK诱导缺血后中枢神经损伤的重要机制。     

EB病毒潜伏膜蛋白1介导c-Jun/JunB活性异源二聚体形成

EB病毒编码的潜伏膜蛋白1可以活化AP-1转录因子, 其中c-Jun和JunB的相互关系和复杂作用一直是人们关注的焦点. 以Tet-on-LMP1 HNE2鼻咽癌细胞系为动态研究模型, 主要应用c-Jun/Jun B双染色间接免疫荧光法联合激光共聚焦荧光显微镜技术、Western blot方法、免疫共沉淀-Western blot方法以及Super-EMSA方法, 同时, 结合信号转导通路研究中的阻断策略, 研究证实EB病毒编码的潜伏膜蛋白1介导c-Jun/Jun B异源二聚体形成, 而且该二聚体具有与DNA结合活性. 该研究为LMP1调控下, AP1二聚体家族成员在不同时空信号传导通路中的动态组合和作用模式提供了新的机制.     

脑缺血Akt和MAPK磷酸酶负性调节c-Jun N端激酶信号通路

目的：探讨脑缺血再灌后Akt和MAPK磷酸酶与JNK活性下调的关系。方法：采用成年清洁级雄性SD大鼠,建立四动脉阻断前脑缺血再灌注模型。缺血10min后再灌注不同时间（15min,1h,4h,24h）。侧脑室分别给予P13K抑制剂LY294002（LY）和MAPK磷酸酶抑制剂放线菌酮（CHO）。免疫印迹观察P-Akt和P-JNK蛋白水平变化。结果：脑缺血再灌注4h,JNK的活性能被Akt抑制剂LY294002增强,表明激活的Akt能够下调JNK信号通路。而MAPK磷酸酶抑制剂放线茵酮能上调缺血后JNK活性,提示MAPK磷酸酶通过去磷酸化参与了JNK的活性抑制。结论：前脑缺血再灌后,激活Akt和MAPK磷酸酶参与了JNK信号通路负性调节,是抑制JNK诱导缺血后中枢神经损伤的重要机制。     

KLF5与c-Jun相互作用促进Ang II诱导的血管平滑肌细胞增殖

KLF5（Krüppel-like factor 5）是KLF家族转录因子中的成员,参与多种与增 殖相关基因的转录调节.通过体外培养大鼠血管平滑肌细胞（vascular smooth muscle cells, VSMC）,以Ang Ⅱ为增殖诱导因素,研究KLF5介导VSMC增殖的机制. 研究发现,Ang Ⅱ可剂量依赖性诱导VSMC增殖,并伴有KLF5和c-Jun蛋白表达水平的 升高.为了证实KLF5参与Ang Ⅱ诱导的细胞增殖过程,用siRNA敲低内源性KLF5的表达后,发现细胞增殖活力受到明显的抑制;交互免疫沉淀和GST pull down分析结果显示,KLF5与c-Jun在体内和体外存在物理学上的相互作用,并且Ang Ⅱ可诱导二者之间的相互缔合.这些结果表明,KLF5通过与c-Jun相互作用进而介导Ang Ⅱ诱导的VSMC 增殖.     

c-Jun N-terminal kinase-mediated Rad18 phosphorylation facilitates Polη recruitment to stalled replication forks

The E3 ubiquitin ligase Rad18 chaperones DNA polymerase η (Polη) to sites of UV-induced DNA damage and monoubiquitinates proliferating cell nuclear antigen (PCNA), facilitating engagement of Polη with stalled replication forks and promoting translesion synthesis (TLS). It is unclear how Rad18 activities are coordinated with other elements of the DNA damage response. We show here that Ser-409 residing in the Polη-binding motif of Rad18 is phosphorylated in a checkpoint kinase 1-dependent manner in genotoxin-treated cells. Recombinant Rad18 was phosphorylated specifically at S409 by c-Jun N-terminal kinase (JNK) in vitro. In UV-treated cells, Rad18 S409 phosphorylation was inhibited by a pharmacological JNK inhibitor. Conversely, ectopic expression of JNK and its upstream kinase mitogen-activated protein kinase kinase 4 led to DNA damage-independent Rad18 S409 phosphorylation. These results identify Rad18 as a novel JNK substrate. A Rad18 mutant harboring a Ser → Ala substitution at S409 was compromised for Polη association and did not redistribute Polη to nuclear foci or promote Polη-PCNA interaction efficiently relative to wild-type Rad18. Rad18 S409A also failed to fully complement the UV sensitivity of Rad18-depleted cells. Taken together, these results show that Rad18 phosphorylation by JNK represents a novel mechanism for promoting TLS and DNA damage tolerance.     

c-Jun is required for TGF-β-mediated cellular migration via nuclear Ca²⁺ signaling

Tumor progression involves the acquisition of invasiveness through a basement membrane. The c-jun proto-oncogene is overexpressed in human tumors and has been identified at the leading edge of human breast tumors. TGF-β plays a bifunctional role in tumorigenesis and cellular migration. Although c-Jun and the activator protein 1 (AP-1) complex have been implicated in human cancer, the molecular mechanisms governing cellular migration via c-Jun and the role of c-Jun in TGF-β signaling remains poorly understood. Here, we analyze TGF-β mediated cellular migration in mouse embryo fibroblasts using floxed c-jun transgenic mice. We compared the c-jun wild type with the c-jun knockout cells through the use of Cre recombinase. Herein, TGF-β stimulated cellular migration and intracellular calcium release requiring endogenous c-Jun. TGF-β mediated Ca(2+) release was independent of extracellular calcium and was suppressed by both U73122 and neomycin, pharmacological inhibitors of the breakdown of PIP(2) into IP(3). Unlike TGF-β-mediated Ca(2+) release, which was c-Jun dependent, ATP mediated Ca(2+) release was c-Jun independent. These studies identify a novel pathway by which TGF-β regulates cellular migration and Ca(2+) release via endogenous c-Jun.     

Ets-1和c-Jun在腺样囊性癌中表达的临床病理研究

目的:观察Ets-1和c-Jun在腺样囊性癌中的表达及在肿瘤侵袭中的意义.方法:收集80例腺样囊性癌病例,根据组织病理学观察分为侵袭组和非侵袭组,用免疫组织化学SP方法分别检测Ets-1和c-Jun在腺样囊性癌组织中的表达.结果:(1)Ets-1、c-Jun在腺样囊性癌组织中的总阳性表达率分别为76.25%(61/80),62.5%(50/80);(2)Ets-1和c-Jun表达在侵袭组和非侵袭组间均有差异,有统计学意义(P(0.05);(3)Ets-1和c-Jun表达间无显著相关性.结论:Ets-1和c-Jun表达与腺样囊性癌的侵袭有关.     

CTx促进远端视神经切断后视网膜节细胞轴突再生与c-Jun表达的关系

目的探讨霍乱毒素(CTx)促进成年金黄地鼠视神经远端切断后视网膜节细胞(RGCs)轴突再生与c-Jun的表达关系。方法远端切断视神经并对接一段自体坐骨神经,玻璃体内注射CTx及/或植入小段坐骨神经分支(SN)。动物随机分为AG CTx组;AG SN组;AG SN CTx组,各组动物分别存活4W,用荧光金(FG)逆行标记和c-Jun免疫荧光组织化学双标法观察轴突再生的RGCs内c-Jun表达情况。结果再生RGCs内有c-Jun蛋白表达,玻璃体内给予CTx或植入SN组RGCs表达c-Jun的再生RGCs分别为35·8±9·57和32·2±7·25个,约占其再生总数的94%及90%,两组相比无显著性差异(P>0·05);CTx与SN联用组c-Jun阳性再生的RGCs为150·2±43·92个,占再生总数的97%,与前两组相比,均有显著性差异(P<0·05)。结论视神经远端切断后约90%以上的再生RGCs有c-Jun表达,提示c-Jun表达与视神经远端受损后节细胞轴突再生密切相关,CTx及外周神经对RGCs轴突再生及c-Jun表达有协同促进作用。     

c-Jun N-terminal kinase regulates soluble Aβ oligomers and cognitive impairment in AD mouse model

Alzheimer disease (AD) is characterized by cognitive impairment that starts with memory loss to end in dementia. Loss of synapses and synaptic dysfunction are closely associated with cognitive impairment in AD patients. Biochemical and pathological evidence suggests that soluble Aβ oligomers correlate with cognitive impairment. Here, we used the TgCRND8 AD mouse model to investigate the role of JNK in long term memory deficits. TgCRND8 mice were chronically treated with the cell-penetrating c-Jun N-terminal kinase inhibitor peptide (D-JNKI1). D-JNKI1, preventing JNK action, completely rescued memory impairments (behavioral studies) as well as the long term potentiation deficits of TgCRND8 mice. Moreover, D-JNKI1 inhibited APP phosphorylation in Thr-668 and reduced the amyloidogenic cleavage of APP and Aβ oligomers in brain parenchyma of treated mice. In conclusion, by regulating key pathogenic mechanisms of AD, JNK might hold promise as innovative therapeutic target.     

棉铃虫c-Jun氨基末端激酶基因的克隆、表达谱及对UV-A胁迫的响应

【目的】本研究旨在克隆棉铃虫Helicoverpa armigera c-Jun氨基末端激酶(c-Jun N-terminal kinase, JNK)基因,并对其进行序列和表达模式分析,探讨该基因在棉铃虫生长发育及响应UV胁迫方面的作用。【方法】利用RT-PCR与RACE技术克隆棉铃虫JNK基因,并利用生物信息学方法对其编码的氨基酸序列进行分析;采用实时荧光定量PCR技术检测其在棉铃虫不同发育阶段(卵、1-6龄幼虫、蛹、雌雄成虫)、成虫不同组织(去除触角和复眼的头、胸、腹、触角、复眼、足、翅、中肠、卵巢)中及雌成虫在UV-A照射不同时间(0, 30, 60, 90, 120和150 min)下的相对表达量变化。【结果】克隆获得一个棉铃虫JNK基因并命名为HaJNK(GenBank登录号:MH719009),其cDNA序列全长为2 431 bp,开放阅读框(ORF)长1 191 bp,编码396个氨基酸,编码蛋白质的相对分子量为45.01 kD,等电点为6.35,无跨膜结构,无信号肽。系统进化分析显示,棉铃虫HaJNK与其他昆虫JNK具有很高的同源性。发育阶段表达分析表明,HaJNK在棉铃虫卵期表达量最高;组织特异性分析显示该基因在成虫复眼、胸部及卵巢部位特异性表达。UV-A照射能诱导棉铃虫雌成虫体内HaJNK的表达,随着照射时间的延长,其表达量呈现先升高后降低的趋势,在照射60 min时表达量达到峰值。【结论】HaJNK在棉铃虫不同龄期、成虫不同组织和UV-A照射不同时间的雌成虫中差异表达,提示其在响应UV-A胁迫的分子机制中具有重要意义。